Drugmakers may bear sole responsibility for overpricing essential medicines under NPPA proposal

The National Pharmaceutical Pricing Authority aims to hold drug manufacturers solely accountable for the excessive pricing of essential medications. This initiative could shield retail chemists and hospitals from legal repercussions concerning pricing infractions. Manufacturers are likely to challenge the proposal, alleging it is uncompromising and unjust. Previously, substantial penalties have been levied against drugmakers for such transgressions.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/Jwgi9SV
via IFTTT

Read More

Jubilant Generics receives show-cause notice demanding over Rs 105 cr

Jubilant Generics received a Rs 105.5 crore GST show-cause notice from Uttarakhand authorities. The notice alleges improper availment of tax refund and Advance Authorisation Scheme benefits. This action pertains to the fiscal years 2020-21 and 2021-22. The company plans to contest the notice and file a detailed reply soon. Jubilant Pharmova expects no significant financial or operational impact.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/m9k6XZl
via IFTTT

Read More

Yatharth Hospitals draws interest from Aster, Advent as healthcare consolidation heats up

Aster DM Quality Care is negotiating to acquire a controlling stake in Yatharth Hospitals. This potential acquisition aims to consolidate the hospital sector amid private equity interest. Yatharth Hospitals' stock has seen a significant rise in anticipation of a potential trade. The deal would trigger an open offer for additional shares, expanding the acquirer's ownership. This move would significantly strengthen Aster DM Quality Care's presence in northern India.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/Kn6AYql
via IFTTT

Read More

Demand for vaccines surges as H1N1, other influenza cases see a sharp rise

Demand for flu vaccines has significantly increased this year. At-home vaccination services are seeing a substantial rise in bookings. Rapid testing requests are also growing from various Indian cities. This surge is driven by elevated viral spread and increased awareness. Experts recommend annual vaccinations and usual protective measures.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/JLdDf1V
via IFTTT

Read More

Convening India's brightest minds: The Bharat Life Sciences Award’s Innovation Summit to spotlight life sciences

India sets its sights on becoming a frontrunner in innovation within the life sciences arena. The Bharat Life Sciences Award 2026 aims to honor exceptional scientific achievements while promoting teamwork. With leaders gathering to enhance manufacturing and drug discovery capabilities, discussions will delve into topics like AI-driven discovery and cutting-edge vaccine technologies, ultimately aiming to define the future of India's life sciences landscape.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/sDSRyfQ
via IFTTT

Read More

Piramal Alternatives invests Rs 215 crore in Kolors Healthcare

Kolors plans to use the latest capital infusion to strengthen its regional footprint while expanding into additional segments of the wellness and preventive healthcare market. The company also plans to implement its "Kolors 2.0" initiative, which involves a broader transformation of its centres and operations.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/C3n1Nld
via IFTTT

Read More

Kedaara pumps $200m into ortho support wear maker Tynor

Kedaara Capital has acquired a majority stake in Tynor Orthotics for approximately $200 million. This significant deal provides an exit for investor Lighthouse Funds from the medical device maker. Tynor Orthotics manufactures orthopaedic supports and mobility aids for global markets. The company has an extensive distribution network reaching numerous retail outlets and hospitals. Kedaara will partner with Tynor's promoters and its existing strategic partner Thuasne.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/c3aRA2F
via IFTTT

Read More